LinkedIn Profile

Access Tecrea historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:tecrea 2540645 Jun 3rd, 2019 12:00AM Tecrea Ltd 212 4.00 Open Biotechnology Jun 3rd, 2019 06:51PM Jun 3rd, 2019 06:51PM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Open Transfection, Small Molecule Drug Delivery, Plasmid Delivery, siRNA Delivery, Peptide Delivery, Protein Delivery, Drug Formulation, Antimicrobial Agents Open 2 Royal College Street London GB NW1 0NH Health Care Equipment & Services
private:tecrea 2540645 Mar 9th, 2018 12:00AM Tecrea Ltd 144 4.00 Open Biotechnology Mar 9th, 2018 08:27AM Mar 9th, 2018 08:27AM Open Health Care Equipment & Services
private:tecrea 2540645 Feb 17th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services
private:tecrea 2540645 Feb 16th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services
private:tecrea 2540645 Feb 15th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services
private:tecrea 2540645 Feb 14th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services
private:tecrea 2540645 Feb 13th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services
private:tecrea 2540645 Feb 12th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services
private:tecrea 2540645 Feb 11th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services
private:tecrea 2540645 Feb 10th, 2018 12:00AM Tecrea Ltd 136 4.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic. Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology. Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.